Quinoline-5,8-diones and methods of using them

Details Quinoline-5,8-diones and methods of using them Quinoline-5,8-diones and methods of using them

1995-06-07

1998-01-27

Rotman, Alan L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514312, 514313, A61K 3147, C07D21516, C07D21518, C07D21533

Patent

active

057122890

ABSTRACT:
The invention provides quinoline-5,8-diones having the following formula: ##STR1## wherein X, Z and R.sup.1 through R.sup.3 are defined in the specification, and salts of these quinolinediones. The invention also provides a method of making the quinolinediones. The quinolinediones have antitumor activity.

REFERENCES:
patent: 3372090 (1968-03-01), Marsh et al.
patent: 3804947 (1974-04-01), Rao
patent: 3933828 (1976-01-01), Kano et al.
patent: 4680299 (1987-07-01), Hesson
patent: 5112837 (1992-05-01), Burrows et al.
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5158960 (1992-10-01), Meyers et al.
patent: 5179093 (1993-01-01), Afonso et al.
Balitz et al., J. Antibiot., 35, 259 (1982).
Basha et al., J. Am. Chem. Soc., 102, 3962 (1980).
Beach, Diss. Abs. Inter., 49, 3204-B (1989).
Behforouz, PRF Annual Report, p. 20 (1990).
Behforouz, PRF Annual Report, p. 119 (1989).
Behforouz, PRF Annual Report, p. 311 (1988).
Boger et al., Tetrahedron Lett., 25, 3175 (1984).
Boger et al., J. Org. Chem., 50, 5782 (1985).
Boger et al., J. Org. Chem., 50, 5790 (1985).
Boger et al., Heterocycles, 24, 1067 (1986).
Boger et al., J. Med. Chem., 30, 1918 (1987).
Chaube et al., Cancer Chemother. Rep. (Part 1), 53, 23 (1969).
Chirigos et al., Cancer Chemother. Rep. Part 1, 57, 305 (1973).
Doyle et al., Tetrahedron Letters, 22, 4595 (1981).
Driscoll et al., Cancer Chemother. Rep. (Part 2), 4, 1 (1974).
Erickson, Diss. Abs. Inter., 49, 747-B (1988).
Gould et al., Fortschr. Chem. Org. Naturst., 41, 77, (1982).
Harris et al., Cancer, 18, 49 (1965).
Herlt et al., J. Antibiot., 38, 516 (1985).
Hibino et al., J. Org. Chem., 42, 232 (1977).
Hibino et al., Heterocycles, 20, 1957 (1983).
Hibino et al., Heterocycles, 23, 261 (1985).
Hibino et al., Chem. Pharm. Bull., 34, 1376 (1986).
Inouye et al., J. Antibiot., 38, 1429 (1985).
Inouye et al., J. Antibiot., 39, 550 (1986).
Inouye et al., J. Antibiot., 40, 105 (1987).
Kaung et al., Cancer, 23, 1280 (1969).
Kende et al., Heterocycles, 21, 91 (1984).
Kende et al., Tetrahedron Letters, 25, 923 (1984).
Kende et al., J. Am. Chem. Soc., 103, 1271 (1981).
Kende et al., Tetrahedron Lett., 48, 4775 (1978).
Kitahara et al., Chem. Pharm. Bull., 38, 2841 (1990).
Kremer et al., Cancer Chemother. Rep., 51, 19 (1967).
Kremer et al., Biochem. Pharmacol., 15, 1111 (1966).
Liao et al., J. Heterocyclic Chem., 13, 1063 (1976).
Liao et al., Angew. Chem. Intern. Edit., 6, 82 (1967).
Liao et al., J. Heterocyclic Chem., 13, 1283 (1976).
Liu et al., J. Antibiot., 45, 454-57 (1992).
Lown et al., Can. J. Chem., 54, 2563 (1976).
Lown et al., Can. J. Biochem., 54, 446 (1976).
Miyasaka et al., J. Chem. Soc. Perkin Trans., 1, 479 (1986).
Mizuno, Biochem. Pharmacol., 16, 933 (1967).
Molina et al., Tetrahedron Lett., 33, 2891 (1992).
Okada et al., J. Antibiot., 40, 230 (1987).
Okada et al., J. Antibiot., 39, 306 (1986).
Panek et al., Diss. Abs. Inter., 46, 1176B (1985).
Preobrazhenskaya et al., J. Antibiot., 45, 227 (1992).
Rao, Cancer Chemother. Rep. (Part 2), 4, 11 (1974).
Rao, J. Heterocyclic Chem., 12, 725 (1975).
Rao, J. Heterocyclic Chem., 14, 653 (1977).
Rao, Recent Progress In Chemical Synthesis Of Antibiotics, 497-531 (Lukacs et al., eds., 1990).
Rao et al., J. Heterocyclic Chem., 12, 731 (1975).
Rao et al., J. Heterocyclic Chem., 16, 1241 (1979).
Rao et al., Indian J. Chem., 23B, 496 (1984).
Rao et al., J. Am. Chem. Soc., 85, 2532 (1963).
Rao et al., Tetrahedron, 42, 5065 (1986).
Rao et al., J. Med. Chem., 34, 1871 (1991).
Renault et al., Eur. J. med. Chem., 16, 24-34 (1981).
Renault et al., Eur. J. med. Chem., 16, 545-50 (1981).
Renault et al., Eur. J. med. Chem., 18, 134-38 (1983).
Rivers et al., Cancer Chemotherapy Rep., 46, 17 (1965).
Shaikh et al., Diss. Abs. Inter., 44, 1464B (1983).
Shaikh et al., J. Med. Chem., 29, 1329 (1986).
Shibata et al., J. Antibiot., 33, 1231 (1980).
Take et al., J. Antibiot., 40, 679 (1987).
Take et al., J. Antibiot., 42, 968 (1989).
Tolstikov et al., J. Antibiot., 45, 1002 (1992).
Tolstikov et al., J. Antibiot., 45, 1020 (1992).
Weinreb et al., J. Am. Chem. Soc., 104, 536-44 (1982).
Wittek et al., J. Org. Chem., 44, 870 (1979).
Yasuda et al., J. Antibiot., 24, 1253 (1987).
Renault et al., J. Med. Chem., 26, 1715-1719 (1983).
Behforouz et al., J. Org. Chem., 58, 7089 (1993).
Boger et al., J. Org. Chem., 50, 5790 (1985).
Boger et al., J. Med. Chem., 30, 1918 (1987).
Kende et al., Tetrahedron Letters, 25, 923 (1984).
Grever, Seminars in Oncology, 19, 622-38 (1992).
Behforouz et al., Abstract of a presentation at the Indiana Academy Of Science, Nov. 5-6, 1992.
Behforouz et al., Abstract of a presentation at the 33rd National Organic Chemistry Symposium, Jun. 13-17, 1993.
Kaiya et al., Heterocycles, 27, 645-49 (1988).
Yanni, Collect. Czech. Chem. Commun., 56, 1919-25 (1991).

Affiliated with

Also associated with

Rating

Quinoline-5,8-diones and methods of using them does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline-5,8-diones and methods of using them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline-5,8-diones and methods of using them will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342676